Novo Nordisk A/S vs Samsung Electronics Co Ltd
A head-to-head of Novo Nordisk A/S (NVO) and Samsung Electronics Co Ltd (SSNLF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | NVO | SSNLF |
|---|---|---|
| Market Cap | $182.56B | $428.21B |
| P/E (TTM) | 2.19 | 31.70 |
| Forward P/E | 12.24 | 4.72 |
| P/S | 0.59 | 0.00 |
| P/B | 1.15 | 3.31 |
| EV/EBITDA | 8.12 | 12.01 |
| Dividend Yield | 23.40% | 0.71% |
| Profit Margin | 33.14% | 13.27% |
| Gross Margin | 80.98% | 39.39% |
| Operating Margin | 41.30% | 13.07% |
| Revenue Growth (YoY) | -7.63% | +23.82% |
| FCF Yield | 15.88% | 8220.63% |
| Debt / Equity | 67.49 | 5.08 |
| Current Ratio | 0.80 | 2.33 |
Which is better: Novo Nordisk A/S or Samsung Electronics Co Ltd?
- ✓Larger by market cap: Samsung Electronics Co Ltd
- ✓Cheaper valuation (lower P/E): Novo Nordisk A/S
- ✓Higher dividend yield: Novo Nordisk A/S
- ✓More profitable (net margin): Novo Nordisk A/S
- ✓Faster revenue growth: Samsung Electronics Co Ltd
- ✓Higher free-cash-flow yield: Samsung Electronics Co Ltd
Across 13 available metrics, Novo Nordisk A/S leads 7–6.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Novo Nordisk A/S with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.